Guidelines and global risk: A European perspective

European Heart Journal, Supplement

Volumn 4, Issue 6, 2002, Pages

  Wood, D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Coronary heart disease; European; Global risk; Guidelines

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COUMARIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTICOAGULATION; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONFERENCE PAPER; CORONARY ARTERY THROMBOSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EUROPE; EXERCISE; FAMILIAL DISEASE; FITNESS; FOOD PREFERENCE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID ANALYSIS; PAROXYSMAL TACHYCARDIA; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SECONDARY PREVENTION; SIDE EFFECT; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM;

EID: 0346838254     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90024-6     Document Type: Conference Paper

References (6)

1. Sans S, Kesteloot H, Kromhout D, on behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-48.
2. Pyörälä K, De Backer G, Graham I, Poole-Wilson PA, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerotic Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-31.
3. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
5. EUROASPIRE Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme. Eur Heart J 2001; 22: 554-72.
6. EUROASPIRE Study Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.